A subsidiary of pharma giant Eli Lilly is to close its manufacturing facility in Sligo with the loss of 100 jobs.
Elanco Animal Health said the decision comes after an in-depth review of its operations, which has also resulted in a decision to close a manufacturing facility in Dundee, Scotland.
The group said cost reduction initiatives, including a major restructuring last year that saw the loss of 70 jobs at its facility in Finisklin Industrial Park in Sligo, had proven ineffective.
The company has been operating in Sligo since 1991. It provides animal health products in more than 70 countries and employs 6,500 people.
“The decision to close the Sligo facility is difficult, and we are very aware of the impact this has on our employees, their families, and the local region,” said Grace McArdle, site manager at Elanco Sligo.
“Over the next few weeks, our priority will be communicating with our employees and providing support at this difficult time,” she added.